Table 1.
Baseline characteristics of 154 patients who underwent potential curative cholecystectomy n (%)
| Characteristic | Patients (n = 154) |
| Age (yr) | 64 (29-85) |
| ≤ 60 | 56 (36.4) |
| > 60 | 98 (63.6) |
| Sex | |
| Male | 63 (40.9) |
| Female | 91 (59.1) |
| Cholecystolithiasis | |
| Absent | 79 (51.3) |
| Present | 75 (48.7) |
| Diabetes | |
| Absent | 116 (75.3) |
| Present | 38 (24.7) |
| Jaundice | |
| Absent | 129 (83.8) |
| Present | 25 (8.9) |
| Blood groups | |
| A | 43 (27.9) |
| B | 56 (36.4) |
| AB | 9 (5.8) |
| O | 46 (29.9) |
| Pathological types | |
| Adenosquamous carcinoma | 3 (1.9) |
| Adenocarcinoma | 150 (97.4) |
| Papillocarcinoma | 1 (0.6) |
| Degree of differentiation | |
| Poor | 60 (39.0) |
| Moderate-well | 94 (61.0) |
| Resection margin status | |
| Negative | 96 (62.3) |
| Positive | 58 (37.7) |
| Maximum tumor diameter (cm) | 3 (0.2-13) |
| ≤ 2.45 | 68 (44.2) |
| > 2.45 | 86 (55.8) |
| T stage | |
| Tis-T1a | 10 (6.5) |
| T1b-T2b | 29 (18.8) |
| T3 | 103 (66.9) |
| T4 | 12 (7.8) |
| N stage | |
| 0 | 98 (63.6) |
| 1 | 47 (30.5) |
| 2 | 9 (5.8) |
| Distant metastasis | |
| Absent | 142 (92.2) |
| Present | 12 (7.8) |
| TNM stage | |
| 0-I stage | 16 (10.4) |
| IIA-IIB stage | 16 (10.4) |
| IIIA-IIIB stage | 92 (59.7) |
| IVA-IVB stage | 30 (19.5) |
| CA199 (U/mL) | 69.3 (0.6-10524) |
| ≤ 25.45 | 57 (37.0) |
| > 25.45 | 97 (63.0) |
| Fibrinogen concentration (g/L) | 3.54 (1.71-7.47) |
| ≤ 3.47 | 75 (48.7) |
| > 3.47 | 79 (51.3) |